The U.S. Food and Drug Administration has banned the sale of Juul e-cigarettes, in a severe blow to the previously successful company due to the high rate of vaping among teens.
The agency stated that, after reviewing data provided by the company for two years, the applications submitted lacked sufficient evidence to confirm that the sale of the products would be appropriate for public health. Some of the findings have raised concerns with the US Food and Drug Administration due to insufficient and contradictory data, including whether potentially harmful chemicals can leach from Juul capsules in e-cigarettes (or vape).
The company has stated that it has appropriately and appropriately defined the toxicological specifications for its products, and that its data conform to the legal standard and are therefore suitable for the protection of public health.
e-cigarette brands such as Juul, British American Tobacco’s Vuse and Imperial Brands’ Blu Inc. meet the September 2020 deadline for submissions to the US Food and Drug Administration showing that the products they manufacture provide a net public health benefit.
Shares of the giant tobacco company Altria, which partially acquires Juul, lost about 7% of their value, equivalent to $6 billion of its market value, after the Food and Drug Administration’s decision to withdraw Juul e-cigarettes from the market.
The Biden administration is seeking other ways to help people quit smoking, which is one of the main causes of cancer, to reduce cancer deaths through prevention. Read more [Tobacco stocks fall after the Biden administration’s scheme to reduce nicotine levels in cigarettes].